Saga Diagnostics

Saga Diagnostics company information, Employees & Contact Information

Explore related pages

Related company profiles:

SAGA Diagnostics is a personalised cancer medicine and disease monitoring company focused on molecular genetic analyses of circulating tumor DNA and tissue biopsies.

Company Details

Employees
99
Founded
-
Address
860 Aviation Pkwy, Morrisville,north Carolina 27560,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Morrisville, North Carolina
Looking for a particular Saga Diagnostics employee's phone or email?

Saga Diagnostics Questions

News

SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection - Business Wire

SAGA Diagnostics® Announces U.S. Commercial Launch of Pathlight™ at ASCO 2025, Setting a New Standard for Ultra-sensitive and Early MRD Detection Business Wire

SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes - Business Wire

SAGA Diagnostics® Announces Medicare Coverage for Pathlight™ MRD Test in Breast Cancer Across All Subtypes Business Wire

SAGA Diagnostics appoints Peter Collins as Chief Executive Officer - PR Newswire

SAGA Diagnostics appoints Peter Collins as Chief Executive Officer PR Newswire

SAGA Diagnostics launches multi-cancer MRD platform in US - Medical Device Network

SAGA Diagnostics launches multi-cancer MRD platform in US Medical Device Network

Editorial: Liquid biopsy: A tool for better understanding of the metastatic process ecosystem - Frontiers

Editorial: Liquid biopsy: A tool for better understanding of the metastatic process ecosystem Frontiers

Saga Diagnostics raises $4.1M for its ultrasensitive cancer blood tests - Fierce Biotech

Saga Diagnostics raises $4.1M for its ultrasensitive cancer blood tests Fierce Biotech

SAGA Diagnostics Launches Early Breast Cancer MRD Detection Test In US - Citeline News & Insights

SAGA Diagnostics Launches Early Breast Cancer MRD Detection Test In US Citeline News & Insights

SAGA Diagnostics enters into an assay development agreement with AstraZeneca - BioSpace

SAGA Diagnostics enters into an assay development agreement with AstraZeneca BioSpace

Sweden: Saga Diagnostics appoints Peter Collins as CEO - Investors in Healthcare

Sweden: Saga Diagnostics appoints Peter Collins as CEO Investors in Healthcare

SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies - PR Newswire

SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies PR Newswire

Saga Diagnostics and AstraZeneca sign dPCR assay development agreement - Medical Device Network

Saga Diagnostics and AstraZeneca sign dPCR assay development agreement Medical Device Network

Top Saga Diagnostics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant